🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7527786

    Methods for inhibiting the growth of cancer cells expressing PSCA

    The Regents of the University of California · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7521414

    Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140

    The Regents of the University of California · Granted Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7494775

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    UT Board of Regents · Granted Tue Feb 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7491802

    Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

    Takeda Pharmaceutical Company Limited · Granted Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7485296

    PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer

    The Regents of the University of California · Granted Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7482002

    Method of administering and using VEGF inhibitors for the treatment of prostate cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7479483

    Tumor-targeted drug delivery systems and uses thereof

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7479272

    Method of administering and using VEGF inhibitors for the treatment of breast cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7479274

    Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7479275

    Method of administering and using VEGF inhibitors for the treatment of colorectal cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7479273

    Method of administering and using VEGF inhibitors for the treatment of renal cell cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7476721

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Jan 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7470431

    Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

    The Regents of the University of Colorado · Granted Tue Dec 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7468432

    Cobalamin conjugates useful as antitumor agents

    Regents of the University of Minnesota · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7442543

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7432349

    Tumor suppressor gene, p28ING5

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7429457

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7429616

    Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

    The Board of Regents of the University of Texas System · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7427496

    Anti-cancer compounds

    The Regents of the University of Colorado · Granted Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7425329

    Methods for treating bone cancer pain by administering a nerve growth factor antagonist

    Regents of the University of Minnesota · Granted Tue Sep 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7419957

    Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7413864

    Treating cancer using a telomerase vaccine

    The Regents of the University of Colorado · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7413873

    Method of detection and treatment of colon cancer

    The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7413870

    SAK: modulation of cellular proliferation for treatment of cancer

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7410644

    Recombinant pox virus for immunization against tumor-associated antigens

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7405314

    Compounds and methods for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7405287

    Method of treating a cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7388088

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7368116

    Method of enhancing a targeted immune response against tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7364726

    Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

    The Regents of the University of California · Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7361332

    Treating tumors using implants comprising combinations of allogeneic cells

    The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7361680

    Indole compounds useful for the treatment of cancer

    The Regents of the University of California · Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7354580

    Method of administering and using VEGF inhibitors for the treatment of human cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7354579

    Method of treating cancer with a VEGF antagonist and an anti-proliferative agent

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7354578

    Method of tumor regression with VEGF inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7355012

    Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7344711

    Use of adenoviruses mutated in the VA genes for cancer treatment

    ONCOLYTICS BIOTECH INC. · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7344829

    Methods for detecting the efficacy of anticancer treatments

    The Board of Regents of the University of Texas System · Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7335382

    Compositions and methods for the treatment and prevention of cancer

    Northwestern University · Granted Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.